Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

EuroIntervention 2016;12:312-318. DOI: 10.4244/EIJV12I3A51

Stefano De Servi
Stefano De Servi1*, MD, FESC; Gabriele Crimi1, MD; Paolo Calabrò2, MD; Federico Piscione3, MD; Marco Cattaneo4, MD; Diego Maffeo5, MD; Anna Toso6, MD; Antonio Bartorelli7, MD; Cataldo Palmieri7, MD; Marco De Carlo8, MD; Davide Capodanno9, MD; Chiara Barozzi10, PhD; Luciana Tomasi10, PhD; Diego Della Riva10, MD; Dominick J. Angiolillo11, MD, PhD; Tullio Palmerini10, MD
1. Unit of Cardiology and Coronary Care Unit, Policlinico San Matteo, Pavia, Italy; 2. Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Seconda Univ di Napoli, A.O. dei Colli, Monaldi, Naples, Italy; 3. Department of Medicine and Surgery, Universi

Aims: In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI, high (H) platelet reactivity (PR) significantly affects one-year outcome. The aim of this rep

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acute coronary syndromesclopidogreldiabetessyntax score
Coronary interventionsNSTEMI
Read next article
Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI

Latest news